WINDLAS BIOTECH
Quarterly Results Analysis [Dec2024]
WINDLAS BIOTECH Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹195 Cr | ₹187 Cr | ₹175 Cr | ₹171 Cr | ₹162 Cr | ₹153 Cr | ₹145 Cr | ₹141 Cr |
Expenses | ₹170 Cr | ₹164 Cr | ₹154 Cr | ₹149 Cr | ₹142 Cr | ₹134 Cr | ₹128 Cr | ₹124 Cr |
Operating Income | ₹25 Cr | ₹23 Cr | ₹21 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹17 Cr | ₹16 Cr |
Other Income | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr |
Profit Before Tax | ₹20 Cr | ₹20 Cr | ₹18 Cr | ₹23 Cr | ₹20 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr |
Profit After Tax | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹17 Cr | ₹15 Cr | ₹14 Cr | ₹12 Cr | ₹11 Cr |
EPS | ₹7.45 | ₹7.49 | ₹6.45 | ₹8.17 | ₹7.26 | ₹6.75 | ₹5.80 | ₹5.47 |
Industry Peers & Returns | 1W | 1M | 1Y |
WINDLAS BIOTECH | -3.6% | -21.4% | 54.8% |
SUN PHARMACEUTICAL INDUSTRIES | -3% | -8.7% | 4.1% |
DIVIS LABORATORIES | -4.7% | -4.5% | 58.5% |
CIPLA | -4.3% | -3.2% | -3.2% |
TORRENT PHARMACEUTICALS | -3% | -12.3% | 13.8% |
DR REDDYS LABORATORIES | -3% | -6.5% | -12.7% |
MANKIND PHARMA | -1.6% | -8% | 9.4% |
ZYDUS LIFESCIENCES | -1% | -8.1% | -5.9% |
LUPIN | NA | -7.7% | 16.6% |
WINDLAS BIOTECH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.29 % |
Y-o-Y | 20.22 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹195 Cr | 4.29 | |
Sep2024 | ₹187 Cr | 6.76 | |
Jun2024 | ₹175 Cr | 2.26 | |
Mar2024 | ₹171 Cr | 5.59 | |
Dec2023 | ₹162 Cr | 6.25 | |
Sep2023 | ₹153 Cr | 5.45 | |
Jun2023 | ₹145 Cr | 2.89 | |
Mar2023 | ₹141 Cr | - |
WINDLAS BIOTECH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 6.86 % |
Y-o-Y | 21.11 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹25 Cr | 6.86 | |
Sep2024 | ₹23 Cr | 10.39 | |
Jun2024 | ₹21 Cr | -5.11 | |
Mar2024 | ₹22 Cr | 8.20 | |
Dec2023 | ₹20 Cr | 8.83 | |
Sep2023 | ₹19 Cr | 9.01 | |
Jun2023 | ₹17 Cr | 4.28 | |
Mar2023 | ₹16 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.43 % |
Y-o-Y | 0.72 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 12.63% | 2.43 | |
Sep2024 | 12.33% | 3.44 | |
Jun2024 | 11.92% | -7.24 | |
Mar2024 | 12.85% | 2.47 | |
Dec2023 | 12.54% | 2.45 | |
Sep2023 | 12.24% | 3.38 | |
Jun2023 | 11.84% | 1.37 | |
Mar2023 | 11.68% | - |
WINDLAS BIOTECH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -0.52 % |
Y-o-Y | 3.17 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹16 Cr | -0.52 | |
Sep2024 | ₹16 Cr | 16.17 | |
Jun2024 | ₹13 Cr | -20.68 | |
Mar2024 | ₹17 Cr | 12.55 | |
Dec2023 | ₹15 Cr | 7.60 | |
Sep2023 | ₹14 Cr | 16.30 | |
Jun2023 | ₹12 Cr | 5.43 | |
Mar2023 | ₹11 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -4.54 % |
Y-o-Y | -14.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 7.99 % | -4.54 | |
Sep2024 | 8.37 % | 8.70 | |
Jun2024 | 7.7 % | -22.38 | |
Mar2024 | 9.92 % | 6.55 | |
Dec2023 | 9.31 % | 1.31 | |
Sep2023 | 9.19 % | 10.32 | |
Jun2023 | 8.33 % | 2.46 | |
Mar2023 | 8.13 % | - |
WINDLAS BIOTECH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -0.53 % |
Y-o-Y | 2.62 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹7.45 | -0.53 | |
Sep2024 | ₹7.49 | 16.12 | |
Jun2024 | ₹6.45 | -21.05 | |
Mar2024 | ₹8.17 | 12.53 | |
Dec2023 | ₹7.26 | 7.56 | |
Sep2023 | ₹6.75 | 16.38 | |
Jun2023 | ₹5.8 | 6.03 | |
Mar2023 | ₹5.47 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD